Meloxicam Recruiting Phase 2 Trials for Ankylosing Spondylitis (AS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02456363Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis